# Risperidone LA Heathcare Resource Study

> **NCT00272597** · PHASE4 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 30 (actual)

## Conditions studied

- Psychosis
- Schizophrenia

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00272597
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00272597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00272597, "Risperidone LA Heathcare Resource Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00272597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*